New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export RADX’s income statement to Excel — free account
Radiopharm Theranostics Limited - Sponsored ADR
RADXRadiopharm Theranostics Limited - Sponsored ADR’s revenue for fiscal 2026 (year ended June 2026) was $1.9 million, down 20.2% from fiscal 2025.
0.63
0.04
−5.97%
After hours trading: 0.60, down 4.76%, last trade Fri 4:27pm Eastern.
Follow RADX
Alert me
What it owns vs. what it owes Q4 FY2026, Jun 30, 2026
Shareholders’ equity is 37.1% of the balance sheet. What is a balance sheet?
Owns
$25.9MLong-term assets
$12.1MOther short-term assets
$2.8MCash & short-term investments
Funded by
$15.2MShareholders’ equity
$25.7MOther liabilities
Debt is 0.00% of the total; shareholders’ equity 37.1%.
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
2.81 | 22.66 | 18.86 | 23.74 |
+1 more quarter Free account |
Receivables |
11.84 | 7.46 | 6.74 | 4.07 | |
Other current assets |
0.23 | 0.11 | 0.22 | 1.09 | |
Total current assets |
14.88 | 30.22 | 25.81 | 28.90 | |
Property, Plant, Equpment (Net) |
— | 0.03 | — | 0.04 | |
Long-Term Investments |
— | — | — | 0.03 | |
Goodwill and Intangible Assets (Total) |
25.90 | 29.59 | 30.16 | 31.27 | |
Total non-current assets |
25.90 | 29.62 | 30.16 | 31.30 | |
Total Assets |
40.81 | 59.85 | 56.01 | 60.23 | |
Accounts Payable |
7.15 | 7.03 | 6.05 | 4.78 | |
Current Part of Capital Lease |
0.00 | — | 0.00 | — | |
Current Part of Taxes to Pay |
0.00 | — | 0.00 | — | |
Current Revenue (Deferred) |
— | 0.67 | — | 2.06 | |
Other current liabilities |
5.68 | 2.34 | 3.62 | 3.79 | |
Total current liabilities |
12.83 | 10.04 | 9.67 | 8.56 | |
Non-current Revenue (Deferred) |
0.00 | — | 0.00 | — | |
Minority Interests |
0.00 | — | 0.00 | — | |
Non-current Liabilities (Other) |
12.84 | 17.02 | 18.57 | 17.79 | |
Total non-current liabilities |
12.84 | 17.02 | 18.57 | 17.79 | |
Total liabilities |
25.66 | 27.06 | 28.24 | 26.35 | |
Additional Paid In Capital |
0.00 | — | 0.00 | — | |
Preferred Stock (Total) |
0.00 | — | 0.00 | — | |
Common Stock (Net) |
142.48 | 137.80 | 114.34 | 109.64 | |
Retained Earnings |
(135.51) | (113.14) | (94.38) | (83.25) | |
Treasury Stock |
0.00 | — | 0.00 | — | |
Shareholders Equity (Other) |
8.18 | 9.33 | 7.80 | 7.50 | |
Common Equity (Total) |
15.15 | 32.78 | 27.76 | 33.88 | |
Shareholders Equity (Total) |
15.15 | 32.78 | 27.76 | 33.88 | |
Shareholders Equity and Liabilities (Total) |
40.81 | 59.85 | 56.01 | 60.23 | |
Shares (Common) |
— | 11.81 | — | 7.34 | |
Shareholders Equity (Tangible) |
(10.75) | 3.19 | (2.40) | 2.61 | |
Net Debt |
(2.81) | (22.66) | (18.86) | (23.74) |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 2, 2026